These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 7921715

  • 1. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G.
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [Abstract] [Full Text] [Related]

  • 2. Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.
    Başoğlu M, Marks IM, Kiliç C, Brewin CR, Swinson RP.
    Br J Psychiatry; 1994 May; 164(5):652-9. PubMed ID: 7921716
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of panic and anxiety in agoraphobia with panic disorder.
    Başoğlu M, Marks IM, Sengün S.
    Br J Psychiatry; 1992 Jan; 160():57-64. PubMed ID: 1347481
    [Abstract] [Full Text] [Related]

  • 4. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia.
    Spiegel DA, Roth M, Weissman M, Lavori P, Gorman J, Rush J, Ballenger J.
    Br J Psychiatry; 1993 Jun; 162():788-9; discussion 790-4. PubMed ID: 8101127
    [No Abstract] [Full Text] [Related]

  • 5. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure.
    Başoğlu M, Marks IM, Swinson RP, Noshirvani H, O'Sullivan G, Kuch K.
    J Affect Disord; 1994 Feb; 30(2):123-32. PubMed ID: 7911132
    [Abstract] [Full Text] [Related]

  • 6. Panic disorder with agoraphobia.
    Klein DF.
    Br J Psychiatry; 1993 Dec; 163():835-7. PubMed ID: 7905776
    [No Abstract] [Full Text] [Related]

  • 7. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
    Marks IM, Swinson RP, Başoğlu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S.
    Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
    [Abstract] [Full Text] [Related]

  • 8. Behavioural and combined therapy in panic states.
    Pecknold JC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Jun; 11(2-3):97-104. PubMed ID: 2888162
    [Abstract] [Full Text] [Related]

  • 9. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Jun; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Ballenger JC.
    J Psychiatr Res; 1990 Jun; 24 Suppl 2():15-25. PubMed ID: 1980694
    [Abstract] [Full Text] [Related]

  • 11. Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder.
    Curran HV, Bond A, O'Sullivan G, Bruce M, Marks I, Lelliot P, Shine P, Lader M.
    Psychol Med; 1994 Nov; 24(4):969-76. PubMed ID: 7892364
    [Abstract] [Full Text] [Related]

  • 12. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia.
    van den Hout M, Arntz A, Hoekstra R.
    Behav Res Ther; 1994 May; 32(4):447-51. PubMed ID: 7910732
    [Abstract] [Full Text] [Related]

  • 13. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 14. Situational exposure treatment versus panic control treatment for agoraphobia. A case study.
    Zarate R, Craske MG, Barlow DH.
    J Behav Ther Exp Psychiatry; 1990 Sep; 21(3):211-24. PubMed ID: 1982290
    [Abstract] [Full Text] [Related]

  • 15. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 16. Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome.
    de Beurs E, Lange A, van Dyck R, Koele P.
    Aust N Z J Psychiatry; 1995 Mar; 29(1):104-13. PubMed ID: 7625959
    [Abstract] [Full Text] [Related]

  • 17. Panic control treatment for agoraphobia.
    Craske MG, DeCola JP, Sachs AD, Pontillo DC.
    J Anxiety Disord; 2003 Mar; 17(3):321-33. PubMed ID: 12727125
    [Abstract] [Full Text] [Related]

  • 18. Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia.
    Craske MG, Rowe M, Lewin M, Noriega-Dimitri R.
    Br J Clin Psychol; 1997 Feb; 36(1):85-99. PubMed ID: 9051281
    [Abstract] [Full Text] [Related]

  • 19. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Feb; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 20. Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.
    Klein DF, Ross DC, Cohen P.
    Arch Gen Psychiatry; 1987 Apr; 44(4):377-85. PubMed ID: 2882736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.